BAILARD, INC.
Q2 2014 13F-HR Holdings
Net value change ($000)
+19,632
(3.1%)
New positions
45
Sold out positions
25
Turnover %
17.2%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2014
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| XLE | 65,126 | NEW |
| EEM | 60,569 | 11216.5% |
| SPY | 3,729 | 4.9% |
| TEVA | 3,680 | NEW |
| AAPL | 2,917 | 59.4% |
| FLAMEL TECHNOLOGIES SA | 2,721 | 338.4% |
| VZ | 2,533 | NEW |
| LEA | 2,054 | NEW |
| WELLPOINT INC | 1,962 | NEW |
| BIODELIVERY SCIENCES INTERNATIONAL INC | 1,914 | 66.2% |
Top Reduces (Value $000, Stocks/ETFs)
| IYR | -55,445 | -97.8% |
| LQD | -55,128 | -99.0% |
| SPDR SERIES TRUST | -10,185 | -29.8% |
| VTI | -4,726 | -10.5% |
| TEKMIRA PHARMACEUTICALS CORP | -2,052 | -100.0% |
| WLK | -1,970 | -100.0% |
| UIS | -1,966 | -88.5% |
| ENDOCYTE INC | -1,912 | -72.3% |
| EXELIS INC COM | -1,907 | -100.0% |
| MPC | -1,758 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|